MedPath

Bariatric Surgery and Guided Self-help for Binge Eating Disorder

Not Applicable
Terminated
Conditions
Obesity
Interventions
Other: Treatment As Usual
Behavioral: Guided Self Help
Registration Number
NCT02094027
Lead Sponsor
Imperial College London
Brief Summary

To demonstrate the effectiveness of an easily administered intervention (guided self help) aimed at reducing binge eating in patients undergoing bariatric surgery.

The investigators hypothesize that patients who have guided self help pre-operatively will have reduced episodes of bingeing pre-operatively compared to those having treatment as usual (bariatric surgery), which will be maintained in the post-operative period, and will be associated with improved weight loss and psychological outcomes after surgery.

Detailed Description

Binge eating disorder (BED) is distressing and common in patients who present for treatment for obesity. Despite this, it is often undiagnosed. Patients who have bariatric surgery have improvements in their eating patterns, including binge eating. However there is variability in the degree of weight loss and post-operative complications following bariatric surgery, associated with disordered eating.

Guided self help for BED (GSH) is a treatment which, like bariatric surgery, is effective in reducing the number of binge episodes in people who binge eat. It is not known whether GSH prior to surgery, in patients undergoing bariatric surgery has any additional benefit for reducing bingeing, or improving weight loss in these patients.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Obese (BMI >28 kg/m2)
  • Pursuing bariatric surgery
Read More
Exclusion Criteria
  • Any illnesses which make the patient unsuitable
  • If the patient is taking any medication which makes them unsuitable
  • If the patient is pregnant or breast feeding
  • If the patient has donated blood in the last three months
  • If the patient has a history of alcoholism or substance dependency within the last 5 years
  • If the patient has a history of major haematological, renal, gastrointestinal, hepatic, respiratory, cardiovascular or psychiatric disease or other illness or use of any medications, including over the counter products, which, in the opinion of the investigators would either interfere with the study or potentially cause harm to the volunteer
  • If the patient has any medical or psychological condition or social circumstances which would interfere with their ability to participate reliably in the trial
  • If the patient is without access to a telephone
  • If the patient is currently receiving or intends to receive treatment with an investigational drug within the next 2 months If the patient is currently receiving or intends to receive treatment for binge eating
  • If the patient currently suffers with severe depression, as indicated by a Beck Depression Inventory Score greater than 28
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Treatment As UsualTreatment As UsualNo intervention for binge eating (treatment as usual in the form of bariatric surgery)
Guided Self HelpGuided Self HelpGuided Self Help intervention to reduce binge eating
Primary Outcome Measures
NameTimeMethod
Change in body mass index pointbaseline, pre-operatively, 3 month, 6 month and 1 year follow up
Secondary Outcome Measures
NameTimeMethod
Complication or reversal of surgery3 month, 6 month and 1 year follow up

Surgical complication or reversal of bariatric surgery as per case notes

Quality of lifebaseline, pre-operative, 3 month, 6 month and 1 year follow up

Score on SF-36, IQoL-lite, Hospital anxiety and depression scale (HADS), and PANAS (positive and negative affect scale)

Drug and alcohol misusepre-operatively, baseline, 3 month, 6 month and 1 year follow up

As measured by AUDIT drug and alcohol assessment tool

Binge episodesbaseline, pre-operatively, 3 month, 6 month and 1 year follow up

-Number of binge episodes per 28 days

Eating behaviourbaseline, pre-operatively, 3 month, 6 month and 1 year follow up

Emotional, externally driven, disinhibited, restrained eating patterns and weight and shape concerns as measured by Eating disorders examination questionnaire (EDE-Q), Dutch Eating Behaviour Questionnaire (DEBQ), Three factor eating questionnaire (TFEQ)

Trial Locations

Locations (1)

Obesity, Endocrine and Medical Clinics at Imperial College Healthcare NHS Trust

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath